Prognostic impact of postoperative complications after neoadjuvant therapy followed by esophagectomy for esophageal cancer: An exploratory analysis of phase III trial JCOG1109.
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial Over the past 15 years, the landscape ...
Comprehensive analysis of socioeconomic and clinical factors contributing to treatment delay in early-onset colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...
Trends and disparities in palliative care utilization among patients with anal cancer: A ten-year retrospective study. Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ ...
A phase 1 trial of folinic acid, fluorouracil, oxaliplatin, bevacizumab, botensilimab, balstilimab (FOLFOX-3B) in microsatellite stable metastatic colorectal cancer. Phase I/II trial of encorafenib, ...
Deep learning–powered analysis of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does ...
Trends in early onset colorectal cancer–related mortality among adults in the United States from 1999-2020. Multi-site blinded validation of a deep learning approach for clinical-grade MSI/dMMR ...
Disparities in incidence and mortality of colorectal cancer in Appalachian Kentucky. Differences in stage at diagnosis, tumor grade, presence of MSI-H, and survival outcomes between younger and older ...
Comparative analysis of demographics and outcomes in hospitalized patients with young- versus average-onset colorectal cancer in New York state (2017-2022). This is an ASCO Meeting Abstract from the ...
A protein-based blood panel test for the early detection of colorectal cancer and advanced neoplasia. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
Association of social deprivation and colon cancer mortality: A population-based analysis. Comparative analysis of demographics and outcomes in hospitalized patients with young- versus average-onset ...
Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal. GOBLET ...